In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Guidelines in Daily Practice III: pharmacological management based on LVEF
Session

Event : Heart Failure 2017

Topic : Other

  • Session type : Guidelines in Daily Practice
  • Date : 30 April 2017
  • Time : 11:00 - 12:30

10 presentations in this session

Case presentation: worsening HFrEF

Event : Heart Failure 2017

  • Session : Guidelines in Daily Practice III: pharmacological management based on LVEF
  • Speaker : EA Bocchi (Sao Paulo,BR)

What do the Guidelines say?

Event : Heart Failure 2017

  • Session : Guidelines in Daily Practice III: pharmacological management based on LVEF
  • Speaker : GMC Rosano (London,GB)

Gaps in evidence.

Event : Heart Failure 2017

  • Session : Guidelines in Daily Practice III: pharmacological management based on LVEF
  • Speaker : G Vergaro (Pisa,IT)

Questions & answers with the audience.

Event : Heart Failure 2017

  • Session : Guidelines in Daily Practice III: pharmacological management based on LVEF

Conclusion and take-home messages

Event : Heart Failure 2017

  • Session : Guidelines in Daily Practice III: pharmacological management based on LVEF
  • Speaker : K Swedberg (Goteborg,SE)

Case presentation: dyspnea and HFmrEF

Event : Heart Failure 2017

  • Session : Guidelines in Daily Practice III: pharmacological management based on LVEF
  • Speaker : Y Lopatin (Volgograd,RU)

What do the Guidelines say?

Event : Heart Failure 2017

  • Session : Guidelines in Daily Practice III: pharmacological management based on LVEF
  • Speaker : B Pieske (Berlin,DE)

Gaps in evidence.

Event : Heart Failure 2017

  • Session : Guidelines in Daily Practice III: pharmacological management based on LVEF
  • Speaker : J Grapsa (London,GB)

Questions & answers with the audience.

Event : Heart Failure 2017

  • Session : Guidelines in Daily Practice III: pharmacological management based on LVEF

Conclusion and take-home messages

Event : Heart Failure 2017

  • Session : Guidelines in Daily Practice III: pharmacological management based on LVEF
  • Speaker : CS Lam (Singapore,SG)

Get your access to resources

Join now
  • 1ESC Professional Members – access all ESC Congress resources 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are